S. Joyce

发表

Inhibition of EGFR-STAT 3 Signaling with Erlotinib Prevents Carcinogenesis in a Chemically-Induced Mouse Model of Oral Squamous Cell Carcinoma

Daniel B. Neill, D. Neill, R. Seethala, 2011 .

Inhibition of EGFR-STAT3 Signaling with Erlotinib Prevents Carcinogenesis in a Chemically-Induced Mouse Model of Oral Squamous Cell Carcinoma

Daniel B. Neill, D. Neill, R. Seethala, 2010, Cancer Prevention Research.

Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer

Lin Wang, J. Grandis, Daniel E. Johnson, 2012, Clinical Cancer Research.

Antitumor effects of EGFR antisense guanidine-based peptide nucleic acids in cancer models.

Simion I. Chiosea, Simon C Watkins, D. Ly, 2013, ACS chemical biology.

Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.

B. Lopresti, J. Grandis, C. Mathis, 2013, American journal of nuclear medicine and molecular imaging.

Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion

A. Egloff, B. Trevelline, J. Sok, 2013, British Journal of Cancer.

Systemic immune dysfunction in cancer patients driven by IL6 induction of LAG3 in peripheral CD8+ T cells.

Simon C Watkins, J. Kirkwood, E. Lipson, 2022, Cancer immunology research.

Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab

R. Seethala, J. Grandis, A. Argiris, 2011, Clinical Cancer Research.

Chronic Prostatitis Induces Bladder Hypersensitivity and Sensitizes Bladder Afferents in the Mouse.

E. Schwartz, J. La, G. Gebhart, 2016, The Journal of urology.

Optogenetic activation of mechanically insensitive afferents in mouse colorectum reveals chemosensitivity.

G. Gebhart, B. Feng, S. Joyce, 2016, American journal of physiology. Gastrointestinal and liver physiology.

A novel role for follistatin in hypersensitivity following cystitis

Amber D. Shaffer, J. La, G. Gebhart, 2017, Neurourology and urodynamics.

JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth12

Simion I. Chiosea, J. Grandis, S. Chiosea, 2015, Neoplasia.

Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3.

Daniel B. Neill, D. Neill, R. Seethala, 2009, Carcinogenesis.

Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors

Daniel B. Neill, D. Neill, J. Grandis, 2010, Clinical Cancer Research.

Antiapoptotic function of NF-κB in T lymphocytes is influenced by their differentiation status: roles of Fas, c-FLIP, and Bcl-xL

M. Boothby, D. Ballard, S. Goenka, 2003, Cell Death and Differentiation.

Mechanism of action of selective inhibitors of IL-6 induced STAT3 pathway in head and neck cancer cell lines

P. Wipf, J. Grandis, D. Huryn, 2017, Journal of chemical biology.

Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer

J. Grandis, Anirban Sahu, S. Thomas, 2012, Molecular Cancer Therapeutics.

Anti-tumor mechanisms of targeting the PDK1 pathway in head and neck cancer

J. Grandis, Anirban Sahu, S. Thomas, 2012 .

Cancer Therapy : Preclinical cSrc Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met

J. Siegfried, J. Grandis, M. Thomas, 2013 .

c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met

J. Siegfried, J. Grandis, S. Thomas, 2012, Clinical Cancer Research.

First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.

Simion I. Chiosea, Joanne I. Yeh, D. Ly, 2012, Cancer discovery.

Systemic immune dysfunction in cancer patients driven by IL6 and IL8 induction of an inhibitory receptor module in peripheral CD8+ T cells

Simon C Watkins, J. Herman, J. Kirkwood, 2020, bioRxiv.

Identification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma.

D. Weeks, Jian-Min Yuan, A. Egloff, 2015, Cancer letters.

First-inHuman Trial of a STAT 3 Decoy Oligonucleotide in Head and Neck Tumors : Implications for Cancer Therapy

Simion I. Chiosea, Joanne I. Yeh, D. Ly, 2012 .

Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit.

J. Grandis, U. Duvvuri, J. Ohr, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.